Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
deals
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
2
×
san francisco top stories
azacitidine
beta-thalassemia
biontech
biotech
boehringer ingelheim
curevac
dacogen
decitabine
dna
eli lilly
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
infectious diseases
insulated genomic domains
john shiver
kaleido biosciences
mahesh karande
moderna therapeutics
mrna
national top stories
omega therapeutics
panobinostat
richard young
robert gould
rudolf jaenisch
sanofi
sickle cell disease
What
medicines
new
2
×
aims
approach
based
bets
bio
biotech
called
cancer
comes
companies
cut
date
deal
debuts
developing
drugs
effective
enticed
epigenetic
epigenetics
evidence
field
flagship’s
hasn’t
latest
messenger
molecules
morning
mrna
multiple
omega
pharmaceutical
primarily
promise
proven
research
rna
sanofi
Language
unset
Current search:
boston
×
new
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
